FEATURED SEARCH: REMS
The day will not be long in coming when pharmaceutical manufacturers no longer retain complete control of the FDA-mandated Risk Evaluation and Mitigation Strategy (REMS), predicts an article in Cancer Network, based on an FDA hearing that involved other stakeholders. The REMS program for erythropoiesis-stimulating agents, in place since March, is the subject of many complaints from oncologists, who say their concerns have not been taken into account.
RESULT: Outside stakeholders seek more input on REMS
Cancer Network | Aug 3, 2010
RESULT: REMS for ESAs: The FDA-mandated program is under scrutiny
HemOnc Today | Jul 10, 2010
An FDA advisory panel roundly rejected a plan to use REMS to try to stem abuse of opiate painkillers. For one thing, they said, pharmas should not be advising you on how to prescribe these drugs. For another, it said, the proposal wasn’t tough enough for the problem.
RESULT: FDA Panel Wants Tougher Restrictions on Opioids
MedPage Today | Jul 23, 2010
___________________________________________________________
SEARCH TIP: NCI Drug Dictionary
Whoever searched for cancer drug information using the query “NCI drug dictionary” didn’t find any results last week, unfortunately.
We had not noticed the dictionary. It’s on the SearchMedica database now, and results should be complete shortly.
However, much of the same information is already available by simply searching on the drug name.
__________________________________________________________
OTHER RECENT SEARCHES ON SEARCHMEDICA
Search: recurrent prostate cancer quality of life
Whoever entered this search term might have concluded that there aren’t many recent studies of prostate cancer that directly assess quality of life. In the top result at the time of writing, the term “quality of life” appeared only in a citation to a 2001 study. However, there has actually been fairly intensive attention to the after-effects of brachytherapy. A Harvard study published last year contained guidance on optimizing the use of brachytherapy with regard to its impact on quality of life. Substituting “patient-reported outcomes” for “quality of life” produced the second study below.
RESULT: Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study
Brachytherapy (PubMed) | Oct 1, 2009
RESULT: Long-term patient-reported outcomes of alternative prostate brachytherapy techniques: Five-year outcomes of a prospective multi-institutional study
ASCO 2010 Genitourinary Cancers Symposium Abstracts | Mar 3, 2010
Search: immunoconjugate review
This review describes new opportunities in nuclear medicine, particularly focusing on multidisciplinary collaboration, using breast cancer imaging as an example.
RESULT: A Bridge Not Too Far: Linking Disciplines Through Molecular Imaging Probes
Journal of Nuclear Medicine | Aug 1, 2010
____________________________________________________________
SEARCH TIP: Radiology channel
The search above appeared not in Hematology/Oncology but in the All of Medicine channel. The Radiology channel is targeted to resources about imaging. It’s best to look there as well as in Hematology/Oncology if your query is relevant to radiation oncology.